Podcast episode 3 (in German)
TB-500 (thymosin beta-4): the regeneration & mobility peptide fact-checked
July 12, 2026
A peptide that does not act in one spot, but travels throughout the body to wherever repair is needed: that is how the regeneration scene describes TB-500. Behind it is an endogenous protein that has occupied research since the 1970s and caused a stir in Nature in 2004.
What it is about
TB-500 is a synthetic fragment of thymosin beta-4, a protein found in practically every cell of the body. It binds to actin, one of the most important structural scaffolds of the cell, and makes it easier for cells to migrate, for example to where a wound needs to be closed. The episode explains why this gave rise to its reputation as a systemic regeneration peptide, what recreational athletes, people after surgery and the longevity scene use it for, and how it differs from BPC-157, which acts more locally; together the two form the so-called Wolverine Stack. At the end stands a molecule with a coherent mechanism and exciting animal and cell data, for which large human studies are still lacking.
Key points
- Thymosin beta-4 was isolated from the thymus by Allan Goldstein in the 1970s, initially as an immune messenger; only later did its role in wound healing and cell movement become apparent.
- In a 2004 paper by the group around Bock-Marquette in Nature, thymosin beta-4 promoted the migration of heart cells and the recovery of the heart muscle in mice after a heart attack.
- On the cornea of the eye, thymosin beta-4 accelerated the healing of injuries; this research extended into early clinical testing.
- The episode names 3 levers: cell migration via actin, formation of new blood vessels and a dampening of excessive inflammation, without completely switching off the inflammation needed for healing.
- In the Wolverine Stack, BPC-157 is considered the fast, local helper of the early healing phase and TB-500 the slow, systemic partner for the later remodeling of the tissue.
- As a report: users describe TB-500 as well tolerated; most frequently mentioned are mild reactions at the injection site, and some report brief fatigue after the injection.
Where the data stop
The most impressive data come from animal models and cell experiments, and the heart and cornea studies mentioned refer to thymosin beta-4 itself, not to the fragment TB-500. There are no large human studies, especially on long-term safety; the good tolerability rests on user reports. The indications of effects on hair growth and skin regeneration are also only indications so far.
TB-500 is a research peptide without approval as a medicine, as of July 2026, and is on the WADA prohibited list; for competitive athletes it is therefore off-limits. Anyone toying with the idea of using it should discuss it with someone knowledgeable and pay attention to quality and origin.
Listen (in German)
Listen on Spotify Listen on Apple Podcasts Listen on Amazon Music
Published on July 12, 2026.
The topic in the database
- The regeneration peptide from the thymosin beta-4 family: in animal models the parent protein promotes wound healing, blood vessel formation and heart repair. TB-500 TB-500 (Thymosin Beta-4 Fragment)
All episodes in the app (German)
Information only, not medical advice and not a usage or dosage recommendation. Prescription-only and unapproved substances belong in the hands of a physician. Last updated: 2026-10-09.